27. Autier P, Boniol M, Pizot C, Mullie P Vitamin D status and ill health: a systematic review. The Lancet Diabetes & Endocrinology.2014;(2):76-89. DOI: 10.1016/ S2213-8587(13)70165-7. Epub 2013 Dec 6
28. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer. 2011;128(6):1414-24. DOI: 10.1002/ijc.25439
29. Xu Y, He B, Pan Y, Deng Q, Sun H, Li R, Gao T, Song G, Wang S. Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Tumor Biology. 2014;35(5):4153-69. DOI: 10.1007/ s13277-013-1544-y
30. Xu Y, Shao X, Yao Y, Xu L, Chang L, Jiang Z, Lin Z. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. Journal of Cancer Research and Clinical Oncology. 2014;140(9):1465-77. DOI: 10.1007/s00432-014-1706-3
31. Zittermann A, Prokop S. The role of vitamin D for cardiovascular disease and overall mortality. Advances in Experimental Medicine and Biology.2014;(810):106-19.
32. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M, RECORD Trial Group. Cardio vascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. The American Journal of Clinical Nutrition. 2014;100(3):746-55.
33. Darnton-Hill I, Mkparu UC. Micronutrients in pregnancy in low- and middle-income countries. Nutrients. 2015;7(3):1744-68. DOI: 10.3390/nu7031744
34. Ozkan S, Jindal S, Greenseid K, Shu J, Zeitlian G, Hickmon C, Pal L. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertility and Sterility. 2010;94(4):1314-19. DOI: 10.1016/j. fertnstert.2009.05.019
35. Мальцева ЛИ, Полукеева АС, Гарифуллова ЮВ. Роль витаминаD в сохраненииздоровья и репродуктивного потенциалаженщин. Практическая медицина. 2015; 1 (86):26-31. [Maltseva LI, Polukeeva AS, GarifullovaYuV. The role of vitamin D for women's health and reproductive potential. Practical Medicine. 2015;1(86):26-31. (In Russian)]
36. Bikle D. Nonclassic actions ofvitamin D. The Journal of Clinical Endocrinology & Metabolism.2009;(94):26-34. DOI: 10.1210/jc.2008-1454
37. Anagnostis P, Karras S, Goulis DG. Vitamin D in human reproduction: a narrative review. International Journal of Clinical Practice. 2013;67(3):225-235. DOI: 10.1111/ijcp.12031
38. Гаврилова ЕС, Яшина ЛМ, Яшин ДА, Сумерки- на ВА. Распространенность биологических факторов риска хронических неинфекционных заболеваний и тревожно-депрессивной симптоматики во взаимосвязи с уровнем лептина сыворотки крови среди студенческой молодежи. Фундаментальныеисследования. 2015; 1 (3):478-82. Ссылка активна на 01.10.2017. [Gavrilova ES, Yashina LM, Yashin DA. Prevalence of biological risk factors of chronic noncommunicable disease and alarm and depression in their interconnection with level of leptin among students. Fundamental Research. 2015; 1 (3):478-82. Accessed October 01, 2017. (In Russian)] http://www.fundamental-research.ru/ru/ article/view?id=37042 (cited 2017 Oct 1
39. Гаврилова ЕС, Яшина ЛМ, Яшин ДА. Распространенность основных факторов риска хронических неинфекционных заболеваний и их взаимосвязь с показателями функции эндотелия и метаболическими нарушениями среди студенческой молодежи. Современныепроблемынауки и образования. 2014; (3). Ссылка активна на 01.10.2017. [Gavrilova ES, Yashina LM, Yashin DA. Prevalence of main risk factors of chronic noncommunicable diseases and their interconnection with endotelian function and metabolic malfunction among students. Modern Problems of Science And Education. 2014; (3). Accessed October 01, 2017. (In Russian)] http:// www.science-education.ru/117-13797
40. Чулков ВлС, Сумеркина ВА, Чулков ВС. Маркеры дисфункции эндотелия и содержание адипокинов у молодых женщин с артериальной гипертензией и абдоминальным ожирением. Уральскиймедицинскийжурнал. 2015;6( 129): 118-21. [ChulkovVlS, Sumerkina VA, Chulkov VS. Markers of endothelial dysfunction and adipokines in young women with hypertension and abdominal obesity. Ural Medical Journal. 2015;6(129):118- 21. (In Russian)]
41. Saha L, Kaur S, Saha PK. Pharmacotherapy of polycystic ovary syndrome: an update. Fundamental & Clinical Pharmacology. 2012; 26(1):54-62.
42. Лиманова ОА, Громова ОА, Торшин ИЮ, Громов АН, Гришина ТР Систематический анализ молекулярно-физиологических эффектов мио-инозитола: данные молекулярной биологии, экспериментальной и клинической медицины. Эффективнаяфармакотерапия. 2013;28(3):32-41. [Limanowa OA, Gromova OA, Torshin IJ, Gromov AN, Grishina TR. Systematic analysis of the molecular and physiological effects of myo-inositol: data of molecular biology, experimental and clinical medicine. Effective Pharmacotherapy. 2013;28(3) :32-41. (In Russian)]
43. MusacchioMC, Cappelli V, Di Sabatino A, MorganteG, De Leo V. Evaluation of the myo-inositol- monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women. Minerva Ginecologica. 2013;65(1):89-97.
44. Whiting L, Danaher RN, Ruggiero K, Lee CC, Chaussade C, Mulvey T, Phillips A, Loomes KM. D-chiro- inositol attenuates epinephrine-stimulated hepatic glucose output in the isolated perfused liver independently of insulin. Hormone and Metabolic Research. 2013;45(5): 394-7. DOI: 10.1055/s-0032-1330016
45. Unfer V, Carlomagno G, Dante G, Facchinetti
F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology. 2012; 28(7):509-15. DOI: 10.3109/09513590.2011.650660
46. Iuorno MJ, JakubowiczDJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, NestlerJE. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice. 2002;8(6):417-23. DOI: 10.4158/ EP8.6.417
47. Minozzi M, Nordio M, Pajalich R. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients. European Review for Medical and Pharmacological Sciences. 2013;17(4):537-40.
48. Cavalli P, Copp AJ. Inositol and folate resistant neural tube defects. Journal of Medical Genetics. 2002;39(2):E5. DOI: 10.1136/jmg.39.2.e5
49. Greene ND, Leung KY, Gay V, Burren K, Mills K, Chitty LS, Copp AJ. Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. British Journal of Nutrition. 2016; (115):974-983. DOI: 10.1017/ S0007114515005322.
50. Ткачева ОН, Громова ОА, Мишина ИЕ, Кле-менов АВ. Макро- и микроэлементный статус при беременности. Дефицит магния и его коррекция при артериальной гипертензии у беременных. M.:Мед- практика-М; 2007. 132 c. [Tkacheva ON, Gromova OA, Mishina IE, Klemenov AV. Macro- and micronutrient status during pregnancy. Magnesium deficiency and its correction in pregnant women with arterial hypertension. Moscow: Medpraktika-M; 2007. 132 p. (In Russian)]
51. Del GobboLC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. The American Journal of Clinical Nutrition. 2013;98(1):160-73. DOI: 10.3945/ajcn.112.053132. Epub 2013 May 29.
52. Ford ES, Li C, McGuire LC, Mokdad AH, Liu S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults. Obesity (Silver Spring). 2007;15(5):1139-46. DOI: 10.1038/oby.2007.628
53. Akarolo-Anthony SN, Jimйnez MC, ChiuveSE, Spiegelman D, WillettWC, Rexrode KM. Plasma magnesium and risk of ischemic stroke among women. Stroke. 2014;45( 10):2881-6. DOI: 10.1161/ STROKEAHA.114.005917. Epub 2014 Aug 12
54. Barker DJ. Developmental origins of chronic disease. Public Health Nutrition.2012;(126):185-9. DOI: 10.1016/j.puhe.2011.11.014
55. Christian P, Stewart CP. Maternal micronutrient deficiency, fetal development, and risk of chronic disease. The Journal of Nutrition. 2010;(140):437-45. DOI: 10.3945 / jn.109.116327
56. Lindeboom M, Portrait F, van den Berg GJ. Long- run effects on longevity of a nutritional shock early in life: The Dutch Potato famine of 1846-1847. Journal of Health Economics.2010;(29):617-29. DOI: 10.1016/j. jhealeco.2010.06.001
57. Lumey LH, Stein AD, Kahn HS, RomijnJA. Lipid profiles in middle-aged men and women after famine exposure during gestation: The Dutch Hunger Winter Families Study. The American Journal of Clinical Nutrition. 2009; (89):1737-43. DOI: 10.3945/ajcn.2008.27038
58. Kim MW, Ahn KH, Ryu KJ, Hong SC, Lee JS, Nava-Ocampo AA, Oh MJ, Kim HJ. Preventive effects of folic acid supplementation on adverse maternal and fetal outcomes. PLoS One.2014;(9): e97273. DOI: 10.1371/ journal.pone.0097273
59. BhuttaZA, Das JK, Rizvi A, GaffeyMF, Walker N, Horton S, Webb P, Black RE. Evidence-based interventions for improvement of maternal and child nutrition: What can be done and at what cost? Lancet 2013; (382):452-477. DOI: 10.1016/S0140-6736(13)60996-4
60. Food Fortification Initiative. Why fortify? Improved health. Accessed October 01, 2017. http://www. ffinetwork.org/why_fortify/health.html